Synthesis of 4-(3'-[125I]iodoanilino)-6,7-dialkoxyquinazolines: Radiolabeled epidermal growth factor receptor tyrosine kinase inhibitors

被引：0
|
作者：
Lim, John K. [1 ,2 ]
Negash, Kitaw [1 ,3 ]
Hanrahan, Stephen M. [1 ]
Vanbrocklin, Henry F. [1 ]
机构：
[1] Lawrence Berkeley National Laboratory, University of California, MS 55-121, 1 Cyclotron Rd., Berkeley, CA 94720, United States
[2] Department of Radiology, University of California, San Francisco, CA 94143, United States
[3] American Cyanamide Co., Agricultural Research Division, Princeton, NJ 08543, United States
来源：
Journal of Labelled Compounds and Radiopharmaceuticals | 2000年 / 43卷 / 12期
关键词：
Amino acids - Enzyme inhibition;
D O I：
10.1002/1099-1344(20001030)43:123.0.CO;2-N
中图分类号：
学科分类号：
摘要：
The preparation of two radioiodinated analogs of the epidermal growth factor receptor tyrosine kinase (EGFrTK) inhibitor PD153035 (4-(3'-bromoanilino)-6,7-dimethoxyquinazoline) are reported herein. The two analogs, 4-(3'-[125I]iodoanilino)-6,7-dimethoxyquinazoline and 4-(3'-[125I]iodoanilino)-6,7-diethoxyquinazoline, were synthesized via iododestannylation of the corresponding 4-(3'-trimethylstannylanilino)-6,7-dialkoxyquinazolines to form the desired I-125 labeled products in good yield, high radiochemical purity (>99%) and high specific activity.
引用
收藏
页码：1183 / 1191
相关论文
共 50 条
  • [21] Tyrosine kinase inhibitors.: 15.: 4-(phenylamino)quinazoline and 4-(phenylamino)pyrido[d] pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor
    Smaill, JB
    Palmer, BD
    Rewcastle, GW
    Denny, WA
    McNamara, DJ
    Dobrusin, EM
    Bridges, AJ
    Zhou, HR
    Showalter, HDH
    Winters, RT
    Leopold, WR
    Fry, DW
    Nelson, JM
    Slintak, V
    Elliot, WL
    Roberts, BJ
    Vincent, PW
    Patmore, SJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (10) : 1803 - 1815
  • [22] Tyrosine kinase inhibitors .12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor
    Rewcastle, GW
    Bridges, AJ
    Fry, DW
    Rubin, JR
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (12) : 1820 - 1826
  • [23] Tyrosine kinase inhibitors.: 17.: Irreversible inhibitors of the epidermal growth factor receptor:: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions
    Smaill, JB
    Rewcastle, GW
    Loo, JA
    Greis, KD
    Chan, OH
    Reyner, EL
    Lipka, E
    Showalter, HDH
    Vincent, PW
    Elliott, WL
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (07) : 1380 - 1397
  • [24] INHIBITION OF EPIDERMAL GROWTH-FACTOR RECEPTOR FUNCTIONS BY TYROSINE KINASE INHIBITORS IN NIH3T3 CELLS
    UMEZAWA, K
    SUGATA, D
    YAMASHITA, K
    JOHTOH, N
    SHIBUYA, M
    FEBS LETTERS, 1992, 314 (03): : 289 - 292
  • [25] CoMFA and CoMSIA 3-D QSAR studies of epidermal growth factor receptor tyrosine kinase inhibitors.
    Buolamwini, JK
    Assefa, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U283 - U283
  • [26] PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors
    Liu, Minghui
    Xu, Song
    Wang, Yuli
    Li, Ying
    Li, Yongwen
    Zhang, Hongbing
    Liu, Hongyu
    Chen, Jun
    ONCOTARGET, 2016, 7 (51) : 84951 - 84964
  • [27] Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitors
    Brunton, VG
    Kelland, LR
    Lear, MJ
    Montgomery, GJ
    Robertson, JH
    Robins, DJ
    Queen, J
    Workman, P
    ANTI-CANCER DRUG DESIGN, 1996, 11 (04): : 265 - 295
  • [28] Synthesis, crystal structure and molecular docking study of new monastrol analogues as inhibitors of epidermal growth factor receptor tyrosine kinase
    Wazalwar, Sachin S.
    Banpurkar, Anita R.
    Perdih, Franc
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1274
  • [29] Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)
    Wissner, A
    Overbeek, E
    Reich, MF
    Floyd, MB
    Johnson, BD
    Mamuya, N
    Rosfjord, EC
    Discafani, C
    Davis, R
    Shi, XQ
    Rabindran, SK
    Gruber, BC
    Ye, F
    Hallett, WA
    Nilakantan, R
    Shen, R
    Wang, YF
    Greenberger, LM
    Tsou, HR
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (01) : 49 - 63
  • [30] 4-anilinoquinazolines with Lavendustin A subunit as inhibitors of epidermal growth factor receptor tyrosine kinase:: syntheses, chemical and pharmacological properties
    Albuschat, R
    Löwe, W
    Weber, M
    Luger, P
    Jendrossek, V
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (12) : 1001 - 1011
12345